These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8962435)
1. Effect of nipradilol, a beta-adrenergic blocker with vasodilating activity, on oxotremorine-induced tremor in mice. Iwata S; Nomoto M; Fukuda T Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):171-4. PubMed ID: 8962435 [TBL] [Abstract][Full Text] [Related]
2. Effects of beta-blockers and nicardipine on oxotremorine-induced tremor in common marmosets. Mitsuda M; Nomoto M; Iwata S Jpn J Pharmacol; 1999 Oct; 81(2):244-6. PubMed ID: 10591485 [TBL] [Abstract][Full Text] [Related]
3. Effects of nipradilol on the microvascular tone of rat mesentery: comparison with other beta-blockers and vasodilators. Araki H; Itoh M; Nishi K Arch Int Pharmacodyn Ther; 1992; 318():47-54. PubMed ID: 1361123 [TBL] [Abstract][Full Text] [Related]
4. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Kanno M; Araie M; Tomita K; Sawanobori K Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):736-43. PubMed ID: 9538880 [TBL] [Abstract][Full Text] [Related]
5. Effect of beta-adrenergic blocking agents, with differing ancillary properties on oxotremorine induced tremor in mice. Alkondon M; Ray A; Sen P Indian J Exp Biol; 1984 Jul; 22(7):382-3. PubMed ID: 6150896 [No Abstract] [Full Text] [Related]
6. Effects of beta-adrenergic blockers on drug-induced tremors. Iwata S; Nomoto M; Fukuda T Pharmacol Biochem Behav; 1993 Mar; 44(3):611-3. PubMed ID: 8095722 [TBL] [Abstract][Full Text] [Related]
7. Modulation of oxotremorine-induced tremor by central beta-adrenoceptors. Hallberg H; Almgren O Acta Physiol Scand; 1987 Mar; 129(3):407-13. PubMed ID: 2883811 [TBL] [Abstract][Full Text] [Related]
8. The role of peripheral catecholamines in oxotremorine tremor in the rat and its antagonism by beta adrenoceptor blocking agents. Weinstock M; Zavadil AP; Rosin AJ; Chiueh CC; Kopin IJ J Pharmacol Exp Ther; 1978 Jul; 206(1):91-6. PubMed ID: 26800 [TBL] [Abstract][Full Text] [Related]
9. The effect of nipradilol on the isoproterenol-induced depression of contractions in the cat soleus muscle. Tanaka T; Murata N; Yamauchi Y Jpn J Pharmacol; 1999 Nov; 81(3):286-91. PubMed ID: 10622217 [TBL] [Abstract][Full Text] [Related]
10. Effects of AIT-082, a purine derivative, on tremor induced by arecoline or oxotremorine in mice. Nannan G; Runmei Y; Fusheng L; Shoulan Z; Guangqing L Pharmacology; 2007; 80(1):21-6. PubMed ID: 17496436 [TBL] [Abstract][Full Text] [Related]
11. Treatment of essential and parkinsonian tremor with nipradilol. Yoshii F; Shinohara Y; Takeoka T; Kitagawa Y; Akiyama K; Yazaki K Intern Med; 1996 Nov; 35(11):861-5. PubMed ID: 8968797 [TBL] [Abstract][Full Text] [Related]
12. Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol. Alkondon M; Ray A; Sen P Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):161-7. PubMed ID: 2865935 [TBL] [Abstract][Full Text] [Related]
13. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol. Um S; Nishida O; Tokubayashi M; Kimura F; Kita T J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997 [TBL] [Abstract][Full Text] [Related]
14. Nipradilol depresses cardiac contractility and O2 consumption without decreasing coronary resistance in dogs. Zhao DD; Namba T; Araki J; Ishioka K; Takaki M; Suga H Acta Med Okayama; 1993 Feb; 47(1):29-33. PubMed ID: 8096354 [TBL] [Abstract][Full Text] [Related]
15. Arotinolol is a weak partial agonist on beta 3-adrenergic receptors in brown adipocytes. Zhao J; Golozoubova V; Cannon B; Nedergaard J Can J Physiol Pharmacol; 2001 Jul; 79(7):585-93. PubMed ID: 11478592 [TBL] [Abstract][Full Text] [Related]
16. Nipradilol protects rat retinal ganglion cells from apoptosis induced by serum deprivation in vitro and by diabetes in vivo. Tatsumi Y; Kanamori A; Nagai-Kusuhara A; Nakanishi Y; Agarwal N; Negi A; Nakamura M Curr Eye Res; 2008 Aug; 33(8):683-92. PubMed ID: 18696344 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor agonists do not cause tremor in the conscious rat. Hallberg H; Almgren O Acta Physiol Scand; 1985 Jun; 124(2):149-52. PubMed ID: 2861714 [TBL] [Abstract][Full Text] [Related]
18. Effects of nipradilol on venous hemodynamics: evaluation with a Doppler blood flow method. Maekawa K; Saito D; Kobayashi H; Mizuo K; Obayashi N; Uchida S; Haraoka S Acta Med Okayama; 1994 Apr; 48(2):87-91. PubMed ID: 8042538 [TBL] [Abstract][Full Text] [Related]
19. [Power spectral analysis of tremor induced by TRH and oxotremorine in mice]. Koja T; Nomoto M; Shimizu T; Izumi K; Fukuda T Nihon Yakurigaku Zasshi; 1986 Aug; 88(2):159-65. PubMed ID: 3095204 [TBL] [Abstract][Full Text] [Related]
20. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]